ORGO Average Annual Return Since 2017
ORGO Average Annual Return Chart Since 2017
Growth of $10,000.00
Without Dividends Reinvested Into ORGO

Also see:
• ORGO stock yearly return 2018
• ORGO stock yearly return 2019
• ORGO stock yearly return 2020
• ORGO stock yearly return 2021
• ORGO stock yearly return 2022
• ORGO stock yearly return 2023
• ORGO stock yearly return 2024
• ORGO stock yearly return 2025
• ORGO YTD return
Average Annual Return Benchmarks
Compare ORGO average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
ORGO Share Performance
ORGO Average Annual Return Table Since 2017
Start date: 01/06/2017
End date: 04/10/2026
Start price/share: $9.75
End price/share: $2.38
Dividends collected/share: $0.00
Total return: -75.59%
ORGO Average Annual Return: -14.13%
Starting investment: $10,000.00
Ending investment: $2,439.80
Years: 9.26


ORGO average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Organogenesis Holdings Inc
Organogenesis Holdings Inc. is a regenerative medicine company developing solutions for advanced wound care, surgical, and sports medicine markets. It offers bioactive and acellular biomaterials, including Apligraf for venous leg ulcers and diabetic foot ulcers (DFUs), Dermagraft for DFUs, PuraPly AM as an antimicrobial barrier, and placental allografts like Affinity, Novachor, and NuShield. In sports medicine, products include NuShield as a surgical barrier and PuraForce for soft tissue repairs, along with PuraPly MZ, PuraPly AM, and PuraPly SX for managing open wounds in surgical settings. The ORGO average annual return since 2017 is shown above.

The Average Annual Return on the ORGO average annual return since 2017 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether ORGO average annual return since 2017 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the ORGO average annual return calculation with any dividends reinvested as applicable (on ex-dates).
ORGO Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree ORGO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
Organogenesis Holdings (ORGO) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

ORGS Average Annual Return
ORIC Average Annual Return
ORKA Average Annual Return
ORMP Average Annual Return
OSUR Average Annual Return
OTLK Average Annual Return
OVID Average Annual Return
OWLT Average Annual Return
PACB Average Annual Return
PACS Average Annual Return
More Healthcare companies »
 

ORGO Average Annual Return Since 2017 | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.